Education
School ¡X Major ¡X Degree | Duration |
---|---|
°ê¥ß¤¤¤s¤j¾Ç ¡X ¥Íª«Âå¾Ç¬ã¨s©Ò(²¦) ¡X ³Õ¤h Doctorate, Institute of Biomedical Sciences, National Sun Yat-sen University |
2008/09 ¡X 2014/06 |
°ª¶¯Âå¾Ç¤j¾Ç ¡X »ùÛ«~¾Ç¨t(²¦) ¡X ¾Ç¤h Bachelor, Department of Fragrance and Cosmetic Science, Kaohsiung Medical University |
2004/09 ¡X 2008/06 |
Intramural Experience
Office/Department/Institute | Position | Duration |
---|---|---|
Ãľǰ|±Ð¾Ç²Õ Academic Affairs Division | Head | 2024/08/01 ¡X 2025/07/31 |
»ùÛ«~¾Ç¨t Department of Fragrance and Cosmetic Science | Associate Professor | 2022/02/01 ¡X |
»ùÛ«~¾Ç¨t Department of Fragrance and Cosmetic Science | Assistant Professor | 2017/02/01 ¡X 2022/01/31 |
Extramural Experience
Discipline
NO | Discipline | Expertise |
---|---|---|
1 | ¥Íª«Âå¹AÃþ Biology, Medicine and Agriculture | ¥Íª«¾Ç¤§¥Í¤Æ¤Î¤À¤l¥Íª« Biochemistry and Molecular Biology |
2 | ¥Íª«Âå¹AÃþ Biology, Medicine and Agriculture | Âå¾Ç¤§¥Í¤Æ¤Î¤À¤l¥Íª« Medical Biochemistry and Molecular Biology |
Research & Technology Platform Open to the Outside
Interested Area(s)for Interdisciplinary Research
Area(s) of Expertise & Research
1. ¥Íª«¾Ç¤§¥Í¤Æ¤Î¤À¤l¥Íª« 2. ¥~ªcÅé
1. Biochemistry and Molecular Biology 2. Exosome
Publication
NO | Publication |
---|---|
1 | Skin colonization by Staphylococcus aureus in hemodialysis patients with pruritus and the effect of Staphylococcus aureus-secreted £\-toxin on filaggrin expression. Skin colonization by Staphylococcus aureus in hemodialysis patients with pruritus and the effect of Staphylococcus aureus-secreted £\-toxin on filaggrin expression. |
2 | High-efficiency ZnO:Al/p-GaN epitaxial heterojunction photocatalysts for, antimicrobial application High-efficiency ZnO:Al/p-GaN epitaxial heterojunction photocatalysts for, antimicrobial application |
3 | Development on potential skin anti-aging agents of Cosmos caudatus Kunth via inhibition of collagenase, MMP-1 and MMP-3 activities. Development on potential skin anti-aging agents of Cosmos caudatus Kunth via inhibition of collagenase, MMP-1 and MMP-3 activities. |
4 | SUMO-Activating Enzyme Subunit 1 Is Associated with Poor Prognosis, Tumor Progression, and Radio-Resistance in Colorectal Cancer. SUMO-Activating Enzyme Subunit 1 Is Associated with Poor Prognosis, Tumor Progression, and Radio-Resistance in Colorectal Cancer. |
5 | Effects of SIDT2 on the miR-25/NOX4/HuR axis and SIRT3 mRNA stability lead to ROS-mediated TNF-£\ expression in hydroquinone-treated leukemia cells. Effects of SIDT2 on the miR-25/NOX4/HuR axis and SIRT3 mRNA stability lead to ROS-mediated TNF-£\ expression in hydroquinone-treated leukemia cells. |
6 | Amsacrine downregulates BCL2L1 expression and triggers apoptosis in human chronic myeloid leukemia cells through the SIDT2/NOX4/ERK/HuR pathway Amsacrine downregulates BCL2L1 expression and triggers apoptosis in human chronic myeloid leukemia cells through the SIDT2/NOX4/ERK/HuR pathway |
7 | Carboxyl Group-Modified Myoglobin Induces TNF-£\-Mediated Apoptosis in Leukemia Cells. Carboxyl Group-Modified Myoglobin Induces TNF-£\-Mediated Apoptosis in Leukemia Cells. |
8 | Resveratrol inhibits matrix metalloproteinase-1 and -3 expression by suppressing of p300/NF£eB acetylation in TNF-£\-treated human dermal fibroblasts Resveratrol inhibits matrix metalloproteinase-1 and -3 expression by suppressing of p300/NF£eB acetylation in TNF-£\-treated human dermal fibroblasts |
9 | Preparation of High-Performance Metal-Free UV/Near Infrared-Shielding Films for Human Skin Protection Preparation of High-Performance Metal-Free UV/Near Infrared-Shielding Films for Human Skin Protection |
10 | Fabrication of oxide-based near infrared-shielding coatings for a smart window to prevent infrared-induced photoaging in human skin Fabrication of oxide-based near infrared-shielding coatings for a smart window to prevent infrared-induced photoaging in human skin |
11 | Carboxyl group-modified £\-lactalbumin induces TNF-£\-mediated apoptosis in leukemia and breast cancer cells through the NOX4/p38 MAPK/PP2A axis. Carboxyl group-modified £\-lactalbumin induces TNF-£\-mediated apoptosis in leukemia and breast cancer cells through the NOX4/p38 MAPK/PP2A axis. |
12 | Evaluation of Gallic Acid-Coated Gold Nanoparticles as an Anti-Aging Ingredient. Evaluation of Gallic Acid-Coated Gold Nanoparticles as an Anti-Aging Ingredient. |
13 | Compound C induces autophagy and apoptosis in parental and hydroquinone-selected malignant leukemia cells through the ROS/p38 MAPK/AMPK/TET2/FOXP3 axis. Compound C induces autophagy and apoptosis in parental and hydroquinone-selected malignant leukemia cells through the ROS/p38 MAPK/AMPK/TET2/FOXP3 axis. |
14 | Blocking of negative charged carboxyl groups converts Naja atra,neurotoxin to cardiotoxin-like protein Blocking of negative charged carboxyl groups converts Naja atra,neurotoxin to cardiotoxin-like protein |
15 | AlbendazoleÂǥѫD¦³µ·¤Àµõ¤§¼vÅT±ø±±¤HÃþ¦åÀù²ÓM³z¹LSIRT3/ROS/p38 MAPK/TTP¤W½ÕTNF-a¦Ó¾ÉP²ÓMä¤` Non-mitotic effect of albendazole triggers apoptosis of human leukemia cells via SIRT3/ROS/p38 MAPK/TTP axis-mediated TNF-£\ upregulation |
16 | ¤T®ñ¤Æ¤G¯~³z¹L§í¨îTET2-FOXP3-Lyn-Akt ¸ô®|½Õ±±MCL1ªí²{»¤¾É¤HÃþ¥Õ¦å¨Ã²ÓMä¤` The suppressive effect of arsenic trioxide on TET2-FOXP3-Lyn-Akt axis-modulated MCL1 expression induces apoptosis in human leukemia cells. |
17 | Membrane-damaging activities of mannosylated ovalbumin are involved in,its antibacterial action Membrane-damaging activities of mannosylated ovalbumin are involved in,its antibacterial action |
18 | Hydroquinone»¤¾ÉFOXP3‑ADAM17‑Lyn‑Akt‑p21°T®§¸ô®|«P¶i¤HÃþ¦åÀù²ÓMU937´c©Ê¤Æ Hydroquinone‑induced FOXP3‑ADAM17‑Lyn‑Akt‑p21 signaling axis promotes malignant progression of human leukemia U937 cells |
19 | Detection of Naja atra Cardiotoxin Using Adenosine-Based Molecular Beacon Detection of Naja atra Cardiotoxin Using Adenosine-Based Molecular Beacon |
20 | ¿}°ò×¹¢¥Õ³J¥Õ¨ã¦³¯}½¤¬¡©Ê Ovalbumin with Glycated Carboxyl Groups Shows Membrane-Damaging Activity |
21 | Quinacrine³z¹LFOXP3/miR-183/£]-TrCP/SP1»¤¾ÉBAXªí²{¼W¥[³y¦¨¤HÃþ«æ©Ê¥Õ¦å¯f²ÓMU937²ÓMä¤` Quinacrine induces the apoptosis of human leukemia U937 cells through FOXP3/miR-183/£]-TrCP/SP1 axis-mediated BAX upregulation |
22 | AmsacrineÂǥѧí¨îAKT»PERK©Ò½Õ±±¤§MCL1éw©Ê¦Ó»¤¾É¤HÃþ¥Õ¦å¯f²ÓMU937²ÓMä¤` Amsacrine-induced apoptosis of human leukemia U937 cells is mediated by the inhibition of AKT- and ERK-induced stabilization of MCL1 |
23 | ¨S¹¤l»Ä×¹¢¤§ª÷©`¦Ì²É¤l¦b¨ÅÀù²ÓMMDA-MB-231¤¤³z¹L°§Cp300éw©Ê»PNFkB/c-Jun¬¡©Ê§í¨îEGF©Ò»¤¾ÉMMP-9ªí²{ Gallic acid-capped gold nanoparticles inhibit EGF-induced MMP-9 expression through suppression of p300 stabilization and NF£eB/c-Jun activation in breast cancer MDA-MB-231 cells |
24 | ¨S¹¤l»Ä§í¨î¤HÃþ¨ÅÀù²ÓMMCF-7¤¤EGFR/Src/Akt/Erk»¤¾É¤§MMP-9ªí²{ Gallic acid abolishes the EGFR/Src/Akt/Erk-mediated expression of matrix metalloproteinase-9 in MCF-7 breast cancer cells |
25 | «ú§Ü¥xÆW«B³Ê¸`£\-Bungarotoxin¤§DNA¾AÅé¥i¿ë»{¥xÆW²´Ãè³D¤ßŦ¬r¯À DNA Aptamers against Taiwan Banded Krait £\-Bungarotoxin Recognize Taiwan Cobra Cardiotoxins. |
26 | 2‐(4‐Aminophenyl)‐7‐methoxybenzothiazole¬¡¤Æp38 MAPK¤W½ÕTNFa/TNFR2ªí²{¦Ó»¤¾É¤HÃþ¦åÀù²ÓMU937²ÓMä¤` The association between p38 MAPK‐mediated TNF‐a/TNFR2 up‐regulation and 2‐(4‐Aminophenyl)‐7‐methoxybenzothiazole‐induced apoptosis in human leukemia U937 cells |
27 | Quinacrine »¤¾É¤HÅé¥Õ¦å¯f K562 ²ÓM³q¹L P38 MAPK ¤Þ°_ BCL 2 ¦V¤U½Õ±± ERK/ c-Jun ©M§í¨î BCL2L1 ªí²{¡C Quinacrine induces apoptosis in human leukemia K562 cells via p38 MAPK-elicited BCL2 down-regulation and suppression of ERK/c-Jun-mediated BCL2L1 expression |
28 | ¤HÃþ¦åÀù²ÓMU937¤¤TNF-a»¤¾ÉNFkB»PAP-1¾ÉP¤§DNA looping½Õ±±MMP-9ªí²{ NFkB-and AP-1-mediated DNA looping regulates matrix metalloproteinase-9 transcription in TNF-a-treated human leukemia U937 cells |
29 | mannosylated bovine serum albumin¨ã¦³§Üµß»P¯}½¤¬¡©Ê Antibacterial and membrane-damaging activities of mannosylated bovine serum albumin |
30 | ¥xÆW²´Ãè³DÁC¯×酶 A2 §í¨î ERK ¤¶¾É ADAM17 µo®i¡A ¦]¦Ó´î¤Ö¦b¤HÃþ¥Õ¦å¯f U937 ²ÓM¤¤ TNF-£\ production ªº¤Àªc¡C Taiwan cobra phospholipase A2 suppresses ERK-mediated ADAM17 maturation, thus reducing secreted TNF-£\ production in human leukemia U937 cells. |
31 | ¤HÃþ¦åÀù²ÓM¦¶K562¤¤simvastatin»¤¾ÉNFkB/p65¤U½Õ»PJNK1/c-Jun/ATF-2¬¡¤Æ¡A¾ÉPMMP-9ªí²{¤U°¦ý¤£¼vÅTMMP-2ªí²{ Simvastatin induces NFkB/p65 down-regulation and JNK1/c-Jun/ATF-2 activation, leading to matrix metalloproteinase-9 (MMP-9) but not MMP-2 down-regulation in human leukemia cells |
32 | ¤HÃþ¦åÀù²ÓM¤¤Amsacrine§í¨î°ò½èª÷ÄݳJ¥Õ酶MMP-2/MMP-9ªí²{ Amsacrine suppresses matrix metalloproteinase‐2 (MMP‐2)/MMP‐9 expression in human leukemia cells |
33 | 'ÁÞ°ò×¹¢BSA¨ã¦³½¤ÂZ°Ê¬¡©Ê Bovine serum albumin with glycated carboxyl groups shows membrane-perturbing activities |
34 | ²´Ãè³D¤ßŦ¬r¯Àªº fusogenicity ¡A¦pÆP©Ê³J¥Õ½è¦bÀTÁC¯×Ånªw¤¤§t¦³®ñ¤ÆÁC¯×©MÁx©T¾J¡C Fusogenicity of Naja naja atra cardiotoxin-like basic protein on sphingomyelin vesicles containing oxidized phosphatidylcholine and cholesterol. |
35 | p38MAPK ©M ERK ¬Û¤¬¤§¶¡ªº¤zÂZ¬O³z¹L¤HÃþ¥Õ¦å¯fU937²ÓM¤¤ MAPK»¤¾É³J¥Õ½èÁC»Ä¤Æ 2A catalytic subunit £\ ©M MAPK phosphatase-1 ªºªí²{¡C Cross talk between p38MAPK and ERK is mediated through MAPK-mediated protein phosphatase 2A catalytic subunit £\ and MAPK phosphatase-1 expression in human leukemia U937 cells. |
36 | ªí²{Bcr/Ablªº¦åÀù²ÓM¤¤¡Ahydroquinone»¤¾ÉmiR-122¤U½Õ¨ÏADAM17ªí²{¼W¥[¡A¶i¦Ó¼W¥[TNF-a¤Àªc Hydroquinone-induced miR-122 down-regulation elicits ADAM17 up-regulation, leading to increased soluble TNF-a production in human leukemia cells with expressed Bcr/Abl |
37 | Guanidinationªºnotexin«P¶iÁC¯×酶A2¿W¥ß¬¡©Ê¿Ä¦XÅnªw»P¯×½è´£¨Ñt¦±²v Guanidination of notexin promotes its phospholipase A2 activity-independent fusogenicity on vesicles with lipid-supplied negative curvature |
38 | ¨S¹¤l»Ä¤U½ÕMMP-2»PMMP-9ªí²{¦bªí²{Bcr/Abl¤§¦åÀù²ÓM¤¤ Gallic acid downregulates matrix metalloproteinase‐2 (MMP‐2) and MMP‐9 in human leukemia cells with expressed Bcr/Abl |
39 | Arecoline³z¹L¤W½Õ²ÓM½¤¤WTNFR2ªí²{»¤¾É¤HÃþ¦åÀù²ÓMK562²ÓMä¤` Arecoline‐induced death of human leukemia K562 cells is associated with surface up‐modulation of TNFR2 |
40 | ¶ÂÀV®g¬r²´Ãè³D CMS- 9¦b¨â©ÊÂ÷¤l©Manionic phospholipid vesiclesªºÁC¯×酶A2¬¡©Ê¨Ì¿à©M«D¿Ä¦X¬¡©Ê¨Ì¿àªºªí²{ Phospholipase A2 activity-dependent and -independent fusogenic activity of Naja nigricollis CMS-9 on zwitterionic and anionic phospholipid vesicles |
41 | Naja nigricollis CMS‐9«P¶iadaphostin³B²zªº¤HÃþ¦åÀù²ÓMU937²É½uÅé¨Ì¿à²ÓMä¤` Naja nigricollis CMS‐9 enhances the mitochondria‐mediated death pathway in adaphostin‐treated human leukaemia U937 cells |
Project
NO |
YEAR ¡X Source ¡X No ¡X Type
Project Name
|
Duration |
---|---|---|
1 |
115 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X NSTC113-2320-B-037-015-MY3 ¡X 1 Ó¤H«¬
±´°Q¸Á¤ý¼ß¤¤²ÓM¥~Ånªw«P¶i¿}§¿¯f¶Ë¤f¡¦Xªº®ÄªG©M¾÷¨î(3/3)( )
|
2026/08/01 ~ 2027/07/31 |
2 |
114 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X NSTC113-2320-B-037-015-MY3 ¡X 1 Ó¤H«¬
±´°Q¸Á¤ý¼ß¤¤²ÓM¥~Ånªw«P¶i¿}§¿¯f¶Ë¤f¡¦Xªº®ÄªG©M¾÷¨î(2/3)( )
|
2025/08/01 ~ 2027/07/31 |
3 |
113 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X NSTC113-2320-B-037-015-MY3 ¡X 1 Ó¤H«¬
±´°Q¸Á¤ý¼ß¤¤²ÓM¥~Ånªw«P¶i¿}§¿¯f¶Ë¤f¡¦Xªº®ÄªG©M¾÷¨î(1/3)( )
|
2024/08/01 ~ 2027/07/31 |
4 |
113 ¡X NK °ªÂå-¤¤¤s¦X§@pµe ¡X NK113P19 ¡X 1 Ó¤H«¬
¸Á¤ý¼ßÃþ¥~ªcÅéÅnªw¹ïÚµ½H»¤¾Éµßªº§Üµß¤Î§Üµoª¢¤§¬ã¨s(Study on the anti-microbial and anti-inflammation effect of royal jelly exosome-like vesicles against acne-inducing bacteria)
|
2024/01/01 ~ 2024/12/31 |
5 |
112 ¡X M °ªÂå(ºØ¤lpµe) ¡X KMU-M113008 ¡X
¶¡½è·F²ÓM¨Ó·½¤§¥~ªcÅ黤¾ÉªÚ»ÖL¨üÅé§@¬°²§¦ì©Ê¥Ö½§ª¢¥Ö½§«Ì»Ù×´_µ¦²¤ªº¬ã¨s( )
|
2024/01/01 ~ 2024/12/31 |
6 |
112 ¡X NK °ªÂå-¤¤¤s¦X§@pµe ¡X ¡X 1 Ó¤H«¬
¨¤½è²ÓM¥~ªcÅé¹ï¥Ö½§«Ì»Ù¥\¯à¤§¼vÅT(The effect of keratinocyte-derived exosomes in skin barrier function)
|
2023/01/01 ~ 2023/12/31 |
7 |
112 ¡X Z ¤j±M¾Ç¥Í¬ã¨spµe¤Î³Õ¤h«á ¡X NSTC113-2813-C-037-059-B ¡X 8 ¤j±M¾Ç¥Í¬ã¨spµe
113¦~«×¤j±M¾Ç¥Í¬ã¨spµe-ªôÀR´ü(ÃľÇ3)( )
|
2024/07/01 ~ 2025/02/28 |
8 |
111 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST111-2320-B-037-027 ¡X 1 Ó¤H«¬
¶¡½è·F²ÓM¤§M¥~Åé©óª÷¶À¦â¸²µå²yµß¤Þ°_¥Ö½§«Ì»Ù·l¶Ë¤§ªvÀø¼ç¤O»P¾÷¨î±´°Q( )
|
2022/08/01 ~ 2023/07/31 |
9 |
111 ¡X NK °ªÂå-¤¤¤s¦X§@pµe ¡X ¡X 1 Ó¤H«¬
±´°Q¤HÃþ¯u¥Ö²ÓMÅÖºû¥À²ÓM¤¤TNF-a¹ïEZH2½Õ±±¤§¾÷Âà(A study on mechanism of TNF-a-regulated EZH2 expression in human dermal fibroblasts)
|
2022/01/01 ~ 2022/12/31 |
10 |
110 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST110-2320-B-037-026 ¡X 1 Ó¤H«¬
§ÜµßÐ`肽©óª÷¶À¦â¸²µå²yµß¤Þ°_¥Ö½§«Ì»Ù·l¶Ë¤§ªvÀø¼ç¤O»P¾÷¨î±´°Q( )
|
2021/08/01 ~ 2022/07/31 |
11 |
110 ¡X NK °ªÂå-¤¤¤s¦X§@pµe ¡X ¡X 1 Ó¤H«¬
¥H¨S¹¤l»ÄÁÙì©`¦Ì²É¤l§í¨î°ò½èª÷ÄݳJ¥Õ酶¦b¤HÃþ¯u¥Ö²ÓM¤§ªí²{( )
|
2021/01/01 ~ 2021/12/31 |
12 |
109 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST109-2320-B-037-008 ¡X 1 Ó¤H«¬
±´°QEZH2¦b¿}§¿¯fºC©Ê¶Ë¤fªºÂ¡¦X¤¤©Ò§êºt¤§¨¤¦â( )
|
2020/08/01 ~ 2021/07/31 |
13 |
109 ¡X NK °ªÂå-¤¤¤s¦X§@pµe ¡X NSYSUKMU109-P008 ¡X 1 Ó¤H«¬
¥H¨S¹¤l»ÄÁÙìª÷©`¦Ì²É¤l§í¨î°ª¿}»¤µo°ò½èª÷ÄݳJ¥Õ酶¦b¤HÃþ¯u¥Ö²ÓM¤§ªí²{( )
|
2020/01/01 ~ 2020/12/31 |
14 |
108 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST108-2320-B-037-033 ¡X 1 Ó¤H«¬
¥Ö½§¤¤Sirt-1¹ïª÷ÄݳJ¥Õ酶²Õ´§í¨î¾¯ªº½Õ±±¤Î¨ä¹ï¶Ë¤f¡¦X¤§¼vÅT( )
|
2019/08/01 ~ 2020/07/31 |
15 |
108 ¡X NK °ªÂå-¤¤¤s¦X§@pµe ¡X NSYSUKMU108-P035 ¡X 1 Ó¤H«¬
TNF-£\ »¤¾É¥Õ¦å¯f²ÓMFOXP3 ¤W½Õªí²{ªº¤À¤l¾÷¨î( )
|
2019/01/01 ~ 2019/12/31 |
16 |
108 ¡X TC ¬ã¨s¤¤¤ßpµe ¡X KMU-TC108A03-7 ¡X 6 ¬ã¨s¤¤¤ß
¸ü»È¦h¯Å¤Õ¥ÍÂå³³²¡©ó°§C°©×´_¤â³N²Óµß·P¬V·ÀI¤§À³¥Î( )
|
2019/08/01 ~ 2020/07/31 |
17 |
107 ¡X NK °ªÂå-¤¤¤s¦X§@pµe ¡X NSYSUKMU107-P008 ¡X 1 Ó¤H«¬
¤T®ñ¤Æ¤G¯~»¤¾É¤H類¥Õ¦å¯f²ÓMä¤`¤§¤À¤l¾÷¨î( )
|
2018/01/01 ~ 2018/12/31 |
18 |
107 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST107-2320-B-037-029 ¡X 1 Ó¤H«¬
¥Ö½§²ÓM¤¤sirt-1¹ï¦h®Þ®a±Ú³J¥Õ¥Ø¼Ð°ò¦]¥Ò°ò¤Æ¤§¬ã¨s( )
|
2018/10/01 ~ 2019/09/30 |
19 |
107 ¡X Q ·s¸u±Ð®vpµe(®Õ¤º) ¡X KMU-Q108010 ¡X
¬õ¥~¥ú»¤¾É¥Ö½§²ÓM¦Ñ¤Æ¤§½Õ±±¾÷¨î( )
|
2019/01/01 ~ 2019/12/31 |
20 |
106 ¡X Q ·s¸u±Ð®vpµe(®Õ¤º) ¡X KMU-Q107001 ¡X
¦X¦¨®ñ¤Æ¾NñS(ZnO:Ga)¯»Åé¹ïªý¹jªñ¬õ¥~¥ú»¤¾É¥Ö½§²ÓM¦Ñ¤Æ¤§®Ä¯àµû¦ô( )
|
2018/01/01 ~ 2018/12/31 |
21 |
106 ¡X Z ¤j±M¾Ç¥Í¬ã¨spµe¤Î³Õ¤h«á ¡X MOST107-2813-C-037-057-B ¡X 8 ¤j±M¾Ç¥Í¬ã¨spµe
107¦~«×¤j±M¾Ç¥Í¬ã¨spµe-§õ©û©É(»ùÛ2)( )
|
2018/07/01 ~ 2019/02/28 |